Search

The article discusses hedge fund manager Marc Mezvinsky's relationship to the family of former U.S. president Bill Clinton as Clinton's son-in-law, noting that a number of investors in Mezvinsky's Eaglevale Partners hedge fund are politically connected to the Clinton family. Topics addressed include investment in Eaglevale by investment firm Rock Creek Group and hedge fund manager Marc Lasry, as well as Mezvinsky's career background.

The article discusses an investment by a hedge fund run by Fletcher Asset Management in the film "Violet & Daisy" whose director, Geoffrey Fletcher, is the brother of Fletcher Asset's founder, Alphonse Fletcher Jr. Commentary is presented on a possible conflict of interest on the part of the hedge fund, an unrealized loss generated by the film for the fund, and bankruptcy proceedings involving funds managed by Fletcher Asset.

The article reports that a hedge fund managed by the Fletcher Asset Management (FAM) investment firm of Alphonse "Buddy" Fletcher Jr. has filed for Chapter 11 bankruptcy protection as of July 2012. It is noted that another fund managed by FAM was ordered to be wound up by liquidators from the firm Ernst & Yong in April 2012 due to insolvency.

The article focuses on financier Philip Falcone, manager of the hedge fund Harbinger Capital Partners. The impact on the fund of a U.S. Federal Communications Commission (FCC) decision denying the telecommunication firm LightSquared Inc. permission to construct a national wireless communication system is examined. Falcone and the hedge fund are the largest investors in LightSquared.

The article reports that hedge-fund manager Philip Falcone of Harbinger Capital Partners LLC has spurned a settlement offer from the U.S. Securities and Exchange Commission (SEC) that would effectively ban him from the securities industry. The SEC is investigating Harbinger regarding several matters including possible market manipulation and a loan Falcone received from Harbinger in 2009.

The article reports that hedge funds are entering a period during which investors wishing to withdraw money must make that fact known. Survey data indicate over one-third of hedge-fund investors have pulled money out or intend to do so. Among notable funds that have suffered from market volatility during 2011 are Pershing Square Capital Management and Paulson & Co.

The article reports that hedge-fund company Longacre Fund Management LLC will close down two of its main funds due to investor withdrawals. Founded in 1998 by John Brecker, Vladimir Jelisavcic, and Steven Weissman, Longacre was hurt by particularly acute market volatility in August 2011, a period when one of its largest funds declined about 7%.

The article discusses the poor performance during 2011 of funds managed by billionaire John Paulson's hedge-fund company Paulson & Co. One fund that concentrates on gold declined over 16% in value during September 2011. A second fund designed to benefit from an improving U.S. economy has fallen over 30% in 2011. A third fund has declined 47%.

The article focuses on financier John Paulson, head of the hedge fund company Paulson & Co. Paulson's reaction to severe 2011 business losses in the largest funds operated by his company is examined, particularly a contrast between his admission to investors that he had made mistakes in investment decisions and his defense of his optimistic economic forecasting for the U.S. which was the fundamental basis of those decisions.

The article reports that a video recording between representatives of hedge-fund company Fletcher Asset Management and pension fund Firefighters' Retirement System of Louisiana shows Denis Kiely of Fletcher telling the fund it would be able to withdraw any money invested with Fletcher within weeks. Firefighters' subsequently invested and has had trouble getting its money returned.

The article discusses how several prominent hedge-fund managers have performed during a stock-market decline in August 2011. The main fund of Ray Dalio's Bridgewater Associates LP has gained about 5% during the month, while Bruce Kovner's Caxton Associates has seen its investments rise 2.6%. Funds managed by John Paulson's Paulson & Co. have fallen a collective 9%.

The article discusses signs that hedge funds were aggressive sellers of stock on August 8, 2011 when the Dow Jones Industrial Average fell over 634 points. Shares widely held by hedge funds including those of banking company Bank of America Corp. and drug company Dendreon Corp. suffered sharper declines than the overall market.

The article reports that hedge fund Citadel LLC has urged online broker E*Trade Financial Corp. to consider selling itself. In a letter to E*Trade chief executive Steven Freiberg Citadel, which has a 9.8% stake in the company, claimed E*Trade had squandered opportunities and failed to act in shareholders' best interests.

The article reports that three Louisiana public pension funds say they will launch an examination of the financial records of hedge fund Fletcher Asset Management. The funds, which collectively have $100 million invested with Fletcher, acted after Fletcher responded to their requests for redemptions by issuing promissory notes.

The article focuses on a ruling by an arbitration panel in favor of Rosen Capital Management LLC (RCM) over broker Merrill Lynch (ML) concerning unexpected margin calls that bankrupted the fund. It states RCM alleged breach of contract, fraud, and negligence, which ML denies. It comments that RCM switched to ML after investment bank Bear Stearns collapsed early in 2008. It mentions that Kyle Rosen, founder of RCM was awarded 63.7 million dollars which will be shared with Rosen fund investors.

The article focuses on possible discrepancies with the hedge fund Fletcher Asset Management. It states the fund, run by hedge-fund manager Alphonse Fletcher Jr., assured 12 percent returns a year. It mentions three public pension boards in Louisiana for firefighters and other public employees signed on in 2008 but were sent promissory notes in satisfaction of the redemption request instead of payment in June 2011. It talks about several unorthodox methods the fund used in calculating its value.

The article looks at FrontPoint Partners LLC, focusing on how the firm's insider-trading scandal has caused Michigan's state pension fund to pull its remaining $375 million in investments from FrontPoint's flagship hedge fund. Information on the FrontPoint insider-trading scandal is presented, noting that a French doctor was arrested for disclosing confidential information on drug trials.

The article reports that hedge-fund company Bridgewater Associates is nearly done raising money for a new $10 billion fund. Founded by Ray Dalio, Bridgewater is among hedge-fund firms that are attracting funds from investors including college endowments and wealthy families eager to take on additional risk.

The article discusses the strong performance of certain hedge funds during 2011. A fund managed by Chris Cooper-Hohn is up about 15% due in part to holdings in media companies such as CBS Corp. and Viacom Inc. Fund manager Chase Coleman of Tiger Global Management LLC has enjoyed healthy gains on investments in video-rental company Netflix Inc. and career-networking Web site LinkedIn Corp.

The article considers a trend in which public employee pension trusts and plans are increasingly investing in hedge funds. The pension trusts are seeking higher rates of return on their investment despite the risks involved with hedge funds rather than seek higher contributions from employers, which might require tax increases, or reducing payments to retirees.

The article discusses the interest of hedge funds and private-equity firms in acquiring distressed debt from European banks. Marathon Asset Management Co., Fortress Investment Group LLC, and OakTree Capital Management are among buyers who have taken advantage of banks' willingness to shed assets at attractive prices.

The article discusses the reaction of attendees at a hedge-fund convention in Las Vegas, Nevada to news that Raj Rajaratnam of the hedge fund Galleon Group had been found guilty of charges related to insider trading. Some said funds that use strategies similar to those employed by Galleon could come under closer government scrutiny. Lee S. Ainslie III of hedge fund Maverick Capital said a verdict of not guilty would have provoked criticism of the industry.

The article reports that total assets under management at hedge funds are rising to levels not seen since the advent of the 2008-2009 global financial crisis. During 2010 hedge funds experienced over $55 billion of net cash inflows. Beneficiaries include relatively smaller funds that some investors have previously been reluctant to use.

The article reports that several hedge funds have been approached by investors making withdrawals from hedge funds Level Global Investors LP and Shumway Capital Partners. Glenview Capital Management LLC and JAT Capital Management LP are among funds who have received expressions of interest from these investors.

The article reports that the Managed Funds Association, a lobbying group for hedge funds, has asked the U.S. Securities and Exchange Commission (SEC) to issue guidelines for the use by funds of "expert network" companies that facilitate contacts between investors and consultants from industry. Expert networks have drawn attention in a U.S. government investigation into insider trading.

The article discusses the impact on pension funds of a U.S. probe into insider-trading that has focused investigators' attention on hedge funds including Level Global Investors LP and Diamondback Capital Management LLC. The School Employees Retirement System of Ohio has invested in both funds, and thus far has made no effort to withdraw any of its money.

The article discusses fund manager Joseph F. Skowron of hedge fund firm FrontPoint Partners LLC. He has been placed on leave following accusations that confidential information provided to a fund manager at FrontPoint by Dr. Yves M. Benhamou helped prevent $30 million in investing losses. Before going into finance Skowron obtained a doctorate in cell biology and was a resident in orthopedic surgery.

The article discusses the case of Dr. Yves M. Benhamou, who has been charged by the U.S. Securities and Exchange Commission with disclosing confidential information about a clinical drug trial to a hedge-fund manager. At the time of his alleged wrongdoing, Benhamou was being paid by consulting firm Guidepoint Global LLC to advise the fund.

The article discusses cash flows into and out of hedge funds during the final quarter of 2011, with commentary presented on an overall outflow of $127 million for the quarter, the ability of large funds with at least $5 billion under management to attract new money, and the industry's investment performance during 2009-2011.

The article discusses factors including volatility in stock prices and a debt crisis in Europe that contributed to disappointing performances by many hedge funds during 2011.

The article reports on the plan of U.S. entrepreneur Oscar Schafer to close its hedge fund O.S.S. Capital Management due to losses that it has incurred as of August 2011.

The article discusses the highlights of the SkyBridge Alternatives Conference that was held in Las Vegas, Nevada in 2011 in which several hedge funds managers offered their stock picks.

The article reports on the possible impact of the new rules under the U.S. Dodd-Frank Act on small hedge fund managers.

The article discusses plans by Aveon Group LP to purchase 30% controlling stakes in nine hedge funds, totaling 3 billion U.S. dollars in combined assets.

The article reports on the decision of hedge funds in the U.S. to lobby against the proposed rules that would force them to turn over more data about their trading positions to the U.S. government.

The article explores the performance of hedge funds in 2010.

The article reports on the move of some hedge fund investors such as Blackstone Group and Goldman Sachs Group Inc. to withdraw money from Philip Falcone's Harbinger Capital Partners LLC.

The article reports that hedge funds, brokers, and other investors are positioning themselves to take advantage of poorly performing assets held by hedge-fund manager John Paulson's Paulson & Co. Some funds have sold assets they hold in common with Paulson out of fear Paulson will be forced to sell to raise cash. Paulson has reportedly turned down low-priced offers he has received for some of his holdings including bonds in defunct investment bank Lehman Brothers Holdings Inc..

The article reports that billionaire George Soros will restrict his hedge-fund company, Soros Fund Management LLC, to managing money exclusively for his family and family foundations. Soros said he was acting to take advantage of provisions in the U.S. Dodd-Frank financial regulatory-reform law that exempt such "family offices" from certain regulations.

The article reports that the Greece-focused hedge fund Eaglevale Hellenic Opportunity owned by Marc Mezvinsky, the son-in-law of former U.S. President Bill Clinton and 2016 presidential candidate Hillary Clinton, will be shutdown by Mezvinsky after the fund lost 90 percent of its value.

The article discusses the financial regulatory environment in the U.S. and the outlook for markets in 2012. Topics noted include the Consumer Financial Protection Bureau, speculation on which financial firms could be deemed systemically important and thus made subject to greater regulation, and how hedge funds will fare after a disappointing 2011.

The article reports that hedge-fund Level Global Investors LP will shut down. Fund founder David Ganek informed investors that his decision was prompted by uncertainty arising from a U.S. investigation into insider trading. Although Ganek said his firm was not a target of that probe, Level Global has been a client of the expert-network firm Primary Global Research LLC, which has been implicated.

The article focuses on insider trading by a French doctor involved in a drug trial for biopharmaceutical corporation Human Genome Sciences Inc. It states that U.S. Federal authorities arrested Dr. Yves M. Benhamou for allegedly tipping the hedge-fund firm FrontPoint Partners, owned by financial company Morgan Stanley, concerning negative news about a drug trial. It mentions that the U.S. Securities and Exchange Commission investigation has not implicated any Morgan Stanley executives.